22nd Century Group, Inc. With a focus on health and wellness, 22nd Century utilizes breakthrough, patent-protected intellectual property to regulate nicotine biosynthesis in tobacco plants, resulting in the development of reduced nicotine content (RNC) tobacco plants and cigarettes that contain an impressive 95% less nicotine. In fact, they are the first and only company to receive FDA authorization for a combustible cigarette.

However, their efforts extend beyond tobacco. 22nd Century Group also applies innovative plant breeding technologies, such as genetic engineering, gene-editing, and molecular breeding, to tobacco, hemp/cannabis, and hop plants. This unique platform allows them to create proprietary plants with specific alkaloid, terpenoid, and flavonoid profiles, enhanced yields, and valuable agronomic traits.

By empowering plants, 22nd Century Group is actively shaping a healthier future, offering solutions for pressing issues in both the life science and consumer products industries. Explore their website to learn more about their cutting-edge research, innovative products, and commitment to promoting well-being